Prognostic value of sST2 and vWF determination in blood serum in patients with arterial hypertension and covid-19
Authors:   Danylo Halytsky Lviv National Medical University, POKROVSKA N. K. , SKLYAROVA H. E. ,   Danylo Halytsky Lviv National Medical University, DENYSENKO N. V. ,   Danylo Halytsky Lviv National Medical University, FOMENKO I. S. ,   Danylo Halytsky Lviv National Medical University, SKLYAROV E. Y. ,   Danylo Halytsky Lviv National Medical University, KOBYLINSKA L. I. ,   Danylo Halytsky Lviv National Medical University
Published: December 2023

Background. The development of the coronavirus disease (COVID-19) occurs against the background of a systemic inflammatory response and can cause an adverse effect on the cardiovascular system. For better diagnosis of disease prognosis, and treatment, determination of sST2 and vWF is import- ant. These markers play an important role in the genesis of thrombosis in the pathophysiology of COVID- 19. Aim of the study. To analyze the prognostic value of sST2 and vWF levels in blood serum of patients with arterial hypertension (AH) and COVID-19. Materials and methods. 71 patients with AH and 16 practically healthy individuals, who were included in the control group, were examined. Patients were divided into two groups: group 1–36 patients with AH who were admit- ted to the hospital with a hypertensive crisis. Group 2 included 35 patients with AH and polysegmental pneumonia on the background of COVID-19. All patients underwent anthropometry, determination of biochemical blood tests, coagulogram, echocardiography (EchoCG), level of sST2 and vWF using ELISA in blood serum. Venous blood sampling was carried out on the 5-7th day after hospitalization against the background of the treatment according to current protocols. Results. The level of sST2 was the highest in the group of patients with AH and COVID-19, while the level of vWF was slightly lower than in patients with AH, which is probably due to the therapy with glucocorticosteroids and low molecular weight heparins. A positive correlation was found between the sST2 level and the size of the left atrium, left ventricle and ejection fraction in patients with AH, while a positive correlation with age was noted in the group of patients with AH and COVID-19 (p < 0.05). Therefore, the level of sST2 was associated with structural changes in the myocardium, which are characteristic of AH and heart failure, which in turn are associated with age-related changes. A positive correlation was established between vWF and the thickness of the posterior wall of the left ventricle, the size of the right ventricle, in patients with AH, while in patients of the group 2, a correlation was found between vWF and the level of leukocytes (p < 0.05). Conclusion. The levels of sST2 and vWF are important markers of disease severity in patients with cardiovascular pathology, as well as COVID-19. In patients with AH and in combination with COVID-19, a significant increase in the concentration of sST2 and vWF was observed compared to practically healthy individuals. Nevertheless, the presence of COVID-19 did not contribute to the emergence of significantly higher values of these markers compared to the group of individuals with AH, which is probably due to the specifics of the infectious pathology treatment.